May 15, 2015 at 08:57 | Source: CNBC-TV18
Here is a list of today's top 10 stocks mostly due to their fourth quarter earnings
May 15, 2015 at 07:51 | Source: Moneycontrol.com
Stocks in news: Ranbaxy | Suzlon Energy | Wockhardt | Nitesh Estates | Arvind | Sequent Scientific | ICICI Bank | Gulf Oil | Mastek | KNR Constructions and Nectar Life are stocks, which are in news today.
May 04, 2015 at 16:59 | Source: CNBC-TV18
Mayuresh Joshi of Angel Broking is of the view that one may prefer Sun Pharma from the pharma space.
Apr 28, 2015 at 11:32 | Source: Reuters
The just completed Ranbaxy deal, its biggest to date at USD 3.2 billion, has given India's biggest drugmaker sufficient scale in generics and emerging markets to think about its next step - beefing up expertise in higher margin products and gaining a bigger global presence.
Apr 28, 2015 at 11:30 | Source: CNBC-TV18
Deepak Shenoy of Capital Mind is of the view that one may prefer Strides Arcolab and Sun Pharma.
Apr 23, 2015 at 14:18 | Source: CNBC-TV18
Jitendra Sriram, MD & Head-Research of HSBC India prefers Infosys and Sun Pharmaceutical Industries.
Apr 22, 2015 at 13:20 | Source: PTI
The company was clarifying on speculations that Sanghvi, who holds 9.61 percent stake in Sun Pharma, had bought shares when Daiichi Sankyo exited from the Indian firm.
Apr 22, 2015 at 12:46 | Source: CNBC-TV18
The pharma space has been in focus post Sun Pharma-Daiichi deal and the likelihood of a possible merger between Teva and Mylan globally. In an interview to CNBC-TV18, Abhishek Sharma of IIFL discusses his outlook on the sector and on specific companies.
Apr 20, 2015 at 20:15 | Source: PTI
As part of the deal, Ranbaxy shareholders were to receive 0.8 Sun Pharma shares for every Ranbaxy share they held. Daiichi Sankyo, which had acquired a majority stake in Ranbaxy in 2008 for around Rs 22,000 crore, held 63.4 percent in the Gurgaon-based firm at the time of the merger.
Apr 20, 2015 at 18:13 | Source: CNBC-TV18
Goldman Sachs is learnt to be the banker to Sun Pharma-Daiichi Sankyo deal.